Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosis

Morie A. Gertz, Martha Q. Lacy, John A. Lust, Philip R. Greipp, Thomas E. Witzig, Robert A. Kyle

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosis'. Together they form a unique fingerprint.

Medicine & Life Sciences